Basiliximab: all 45 studies that test it

Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic DiseasesNot yet recruitingNCT06480630Phase 2
• Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal InvolvementRecruitingNCT06066840Phase 4
• Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin LymphomaRecruitingNCT04871607Phase 2
• Standard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant RecipientsRecruitingNCT04404127Phase 4
• Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver TransplantCompletedNCT04104438Phase 4Results posted
• Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant RecipientsCompletedNCT03663335Phase 2Results posted
• Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal TransplantCompletedNCT02464878Phase 2Results posted
• DC Migration Study for Newly-Diagnosed GBMCompletedNCT02366728Phase 2Results posted
• Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver TransplantationCompletedNCT02123108Phase 4Results posted
• Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT01884571Phase 2Results posted
• Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host DiseaseTerminatedNCT01485055Phase 2Results posted
• Basiliximab #2: In-Vivo Activated T-Cell Depletion to Prevent Graft-Versus_Host Disease (GVHD) After Nonmyeloablative Allotransplantation for the Treatment of Blood CancerCompletedNCT00975975Phase 2Results posted
• Belatacept in Liver Transplant RecipientsTerminatedNCT00555321Phase 2Results posted
• A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant RecipientsCompletedNCT00369161Phase 4Results posted
• Everolimus in a Cyclosporine Microemulsion-free Regimen Compared to a Low-dose Cyclosporine Microemulsion Regimen, in de Novo Kidney Transplant PatientsCompletedNCT00154284Phase 3Results posted
• Efficacy and Safety of Basiliximab, Cyclosporine/Cyclosporine Microemulsion, and Steroids in Pediatric de Novo Liver Transplant Recipients Avoiding Intraoperative SteroidsCompletedNCT00149890Phase 3Results posted
• 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic SyndromeActive, not recruitingNCT05139004Phase 1
• Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult PatientsStatus unknownNCT05013034Phase 2
• Combination of Basiliximab and Pegaspargase in the Treatment of ENKTCLStatus unknownNCT04337593Phase 2
• Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft OutcomeCompletedNCT03794492Phase 4
• Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney TransplantationStatus unknownNCT03789006Phase 4
• Basiliximab Treating Interstitial Pneumonia of CADMStatus unknownNCT03192657Phase 2
• Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia MajorStatus unknownNCT03171831Phase 4
• Simulect Versus ATG in Sensitized Renal Transplant PatientCompletedNCT02377193Phase 4
• Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia MajorCompletedNCT02342145Phase 4
• Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete RemissionCompletedNCT01842139Phase 1
• Stem Cell Transplantation for Patients With Multiple MyelomaCompletedNCT01526096Phase 1
• Basiliximab Maintenance in Ulcerative ColitisTerminatedNCT01061996Phase 2
• Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver TransplantationCompletedNCT01011205Phase 3
• Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney TransplantTerminatedNCT00928811Phase 2/3
• Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver TransplantationStatus unknownNCT00890253Phase 2
• Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal TransplantationCompletedNCT00724022Phase 4
• A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney RejectionCompletedNCT00717470Phase 4
• The Safety and Efficacy of Basiliximab as Maintenance Therapy in Subjects With Stable, Noninfectious UveitisTerminatedNCT00646425Phase 2
• Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused LymphopeniaCompletedNCT00626483Phase 1
• Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell TransplantationStatus unknownNCT00563108Not applicable
• Strategies to Improve Islet SurvivalCompletedNCT00464555Phase 2
• Islet Transplantation in Type 1 DiabetesCompletedNCT00434811Phase 3
• Basiliximab in Moderate to Severe Ulcerative ColitisCompletedNCT00430898Phase 2
• Prospective, Randomized Trial of Basiliximab (Simulect) in the Prophylaxis of High-Risk Keratoplasty PatientsCompletedNCT00409656Phase 2
• An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.CompletedNCT00343226Phase 4
• EXTEND Protocol for Transplanted Patient to Evaluate Kidney FunctionStatus unknownNCT00302497Phase 3
• Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and SteroidsCompletedNCT00284947Phase 4
• Efficacy and Safety of Basiliximab in Hepatitis C Virus Positive Patients Undergoing Liver TransplantationCompletedNCT00238901Phase 3
• Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung TransplantCompletedNCT00188825Phase 3

← Basiliximab overview